Acadia Healthcare Raises 2026 Guidance on Strong Q3 Growth
Event summary
- Acadia Healthcare reported $895.3 million in Q3 2026 revenue, up 5.1% YoY.
- Same-facility revenue increased 5.2%, driven by a 1.1% rise in patient days and a 4.0% increase in revenue per patient day.
- Adjusted EBITDA rose to $176.4 million, up from $173.0 million in Q3 2025.
- The company added 220 licensed beds, including a 144-bed facility near Jacksonville, Florida.
- Full-year 2026 guidance was raised, with revenue now expected between $3.44B and $3.46B.
The big picture
Acadia Healthcare's Q3 2026 results reflect continued growth in the behavioral healthcare sector, driven by increased patient demand and strategic facility expansions. The company's raised full-year guidance underscores its confidence in sustaining this momentum, despite potential regulatory headwinds from the OBBBA. As the largest stand-alone behavioral healthcare provider in the U.S., Acadia's performance offers insights into the broader trends in mental health and addiction treatment services.
What we're watching
- Expansion Strategy
- How Acadia's addition of 220 licensed beds will impact its operational efficiency and market reach.
- Regulatory Impact
- Whether the One Big Beautiful Bill Act (OBBBA) will affect Acadia's revenue streams and operational costs.
- Financial Discipline
- The pace at which Acadia can maintain its financial discipline while expanding its footprint.
Related topics
